Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

By Payne Kyle   Zoon Christine   Wan Wen   Marlar Khin   Keim Rebecca   Kenari Mehrab   Kazim A.   Bear Harry   Manjili Masoud  

Breast Cancer Research and Treatment, Vol. 142, Iss. 1, 2013-11 ,pp. : 45-57

Springer Publishing Company

Access to resources Recommend Favorite

Mechanism of action of anti-HER2 monoclonal antibodies

By Baselga J.   Albanell J.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 35-41

Springer Publishing Company

Access to resources Recommend Favorite

A Caspase-6 and Anti-HER2 Antibody Chimeric Tumor-Targeted Proapoptotic Molecule Decreased Metastasis of Human Osteosarcoma

By Wang Li-Feng   Zhou Yong   Xu Yan-Ming   Qiu Xiu-Chun   Zhou Ben-Gen   Wang Fang   Long Hua   Chen Xiang   Yang Tong-Tao   Ma Bao-An   Fan Qing-Yu   Yang An-Gang  

Cancer Investigation, Vol. 27, Iss. 7, 2009-08 ,pp. : 774-780

Informa Healthcare

Access to resources Recommend Favorite

Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells

By Catania Angela   Barrajón-Catalán Enrique   Nicolosi Silvia   Cicirata Federico   Micol Vicente  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 55-65

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 2, 2012-02 ,pp. : 151-162

Bentham Science Publishers

Access to resources Recommend Favorite